Cardiac Rhythm Management Devices Market - Top Companies and Manufacturers

Companies Dominating the cardiac rhythm management devices Landscape

The cardiac rhythm management devices market is dominated by key market players who are gaining traction in the market by adopting several strategies including merger and acquisitions.

Vitatron Holding B.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Medtronic
Biotronik
Abbott
ABIOMED
Stryker Corporation
Amiitalia.
© BPL Medical Technologies
OSYPKA MEDICAL
MicroPort Scientific Corporation

Browse Key Market Insights with Data Illustration:

Cardiac Rhythm Management Devices Market Size Forecasts 2036

In the News

Medtronic’s PulseSelect Pulsed Field Ablation (PFA) System was approved by the US Food and Drug Administration (FDA) to treat paroxysmal and persistent atrial fibrillation (AF), according to an announcement made by the firm. Following the PulseSelect PFA system's November European CE (Conformité Européenne) Mark, this is the first PFA technology to be approved by the FDA.
Abbott announced that the US Food and Drug Administration has approved the AssertIQTM insertable cardiac monitor, providing physicians with a new option for diagnostic evaluation and long-term monitoring of patients who experience an irregular heartbeat. This clearance builds on Abbott's portfolio of connected medical devices that can help doctors better manage and treat their patients remotely.

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of cardiac rhythm management devices was over USD 18 billion.

The market size for cardiac rhythm management devices is projected to cross USD 40 billion by the end of 2036 expanding at a CAGR of 7% during the forecast period i.e., between 2024-2036.

The major players in the market are Vitatron Holding B.V., Medtronic, Biotronik, Abbott, ABIOMED, Stryker Corporation, Amiitalia., Â© BPL Medical Technologies, OSYPKA MEDICAL, MicroPort Scientific Corporation, and others.

The pacemakers segment is anticipated to garner a share of 38% during 2024-2036.

The North American cardiac rhythm management devise sector is poised to hold 36% share by the end of 2036.

Cardiac Rhythm Management Devices Market - Top Companies and Manufacturers

Companies Dominating the cardiac rhythm management devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the cardiac rhythm management devices industry?

What is the outlook for the cardiac rhythm management devices market?

Who are the major players dominating the cardiac rhythm management devices landscape?

Which segment will capture the significant market share for cardiac rhythm management devices by 2036?

Which region will provide more opportunities for the cardiac rhythm management devices business in the near future?